Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ESA title
Personalised Medicine Approaches to Space Exploration - SciSpacE

Personalised Medicine Approaches to Space Exploration

Each astronaut is unique and predisposition to physiological changes during spaceflight and response to medicines, both efficacy and toxicity, are dependent on a combination of factors including environment and genetics. Personalised medicine aims to move away from a ‘one-size fits all’ approach to one which uses innovative approaches, such as –omics technologies, to be able to determine individual benefit-risk of drug treatment to ensure the most effective interventions or countermeasures to improve health.

The aims of this Topical Team are to explore how personalised medicine approaches can optimise astronaut drug safety and efficacy and identify risk factors that predispose astronauts to negative effects of space exploration. The medications that are currently available on the ISS are commonly used drugs that have been on the market for a long time. However, in modern medicine, even more effective medicines may be available in terrestrial practice. This Topical Team shall focus on the development of a “future space exploration package” implementing Personalized Medicine for astronauts with the aims to ensure optimal drug treatment in future space exploration journeys and gather scientific evidence on specific gene-space-conditions-interactions that may characterize an astronaut specific benefit-risk profile for drug treatment in space medicine. Identification of personalized susceptibility factors for negative effects of space exploration will enable bespoke countermeasures maximizing astronaut safety and mission success.